In looking at the scope issues, it might be helpful to examine the 18 places where the August 25, 2010 version of the ACTA text uses the term, “at least.”
Page 7
ARTICLE 2.x: GENERAL OBLIGATIONS WITH RESPECT TO ENFORCEMENT
2.X.2
Continue Reading
On October 14, 2009, KEI submitted a FOIA request to the USTR, which is available here, asking for the following records:
KEI requests all records at USTR on the topic of the policy and practice of USTR regard the transparency of trade negotiations, including but not limited to the Anti-Counterfeiting Trade Agreement (ACTA).
Part 1 of our notes on the August 25, 2010 version of the ACTA consolidated text, covering pages 1-9 of the text, are available here. These notes cover the remainder of August 25, 2010 ACTA text, from pages 10 to 29.
The U.S. Department of Commerce has been given a high profile role in intellectual property policies in the Obama Administration. The Department is headed by Secretary of Commerce Gary Locke. Locke is the best known as the former two term governor of the State of Washington. After leaving the government, he has also been a lawyer and consultant, including to Microsoft. Here are a few data points on that relationship.
Continue Reading
Part 1: Notes on the August 25, 2010 version of the ACTA consolidated textKEI has obtained a copy of the August 25, 2010 version of the ACTA consolidated negotiating text. This is Part 1 of our initial notes on the document. (Part 2 is available here.) (revised September 9, 2010) PreambleThe preamble in the August, 25, 2010 text includes 10 paragraphs, of which only 3 do not have brackets. Testinghttp://goo.gl/p6a15d https://docs.google.com/presentation/d/1ElI6rxLsq1SAlB69bsvti1_sK6A7W7pXP6Zmn7WM_lc/pub?start=false&loop=false&delayms=3000 Continue Reading Lunch with the ACTA negotiators, August 17, 2010On Tuesday, August 17, 2010, USTR organized a lunch between ACTA negotiators and civil society NGOs. There was not much notice. We received our invite to the lunch last Thursday. Representatives from KEI, Public Citizen, Oxfam, Public Knowledge and the American University program on intellectual property attended the event. The US Orphan Drug Tax CreditFrom the FDA page on the Orphan Drug Tax Credit. Incentives TAX CREDIT (See Footnote 1 below) FOR TESTING EXPENSES FOR DRUGS FOR RARE DISEASES OR CONDITIONS Introduction Section 45C of the Internal Revenue Code of 1954 allows a credit… Continue Reading Notes and data points for prices of orphan productsFebruary 22, 2010., Matthew Herper, “The World’s Most Expensive Drugs,” Forbes. Genzyme’s web page on the cost of treatment. Some data points on Fabrazyme prices. 2004 prices for Replagal 2001 prices for Cerezyme. Myozyme/Lumizyme A 2007 Canadian analysis of (50… Continue Reading Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures
Written submission U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Hearing on Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures, On the topic of Direct funding, subsidies and incentives for the development… Continue Reading |